SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
200 hedge funds and large institutions have $1.23B invested in Sage Therapeutics in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 45 increasing their positions, 78 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
200
Holders Change
+7
Holders Change %
+3.63%
% of All Funds
2.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
40
Increased
45
Reduced
78
Closed
31
Calls
$14.9M
Puts
$7.46M
Net Calls
+$7.41M
Net Calls Change
-$3.56M
Top Buyers
| 1 |
CAC
1
Cowen and Company
New York
|
$29M |
| 2 |
2
Morgan Stanley
New York
|
$37.7M |
| 3 |
3
BlackRock
New York
|
$101M |
| 4 |
4
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$16.1M |
| 5 |
5
Voloridge Investment Management
Jupiter,
Florida
|
$8.51M |
